Report

  1. Home
  2. Discounted reports

Corneal implants Market By Procedure Type (Penetrating keratoplasty, Endothelial keratoplasty, Others), By Disease Type (Keratoconus, Fuchs' dystrophy, Infectious keratitis, Others), By End User (Hospitals, Ophthalmic centers, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031

Market Report I 2023-04-01 I 330 Pages I Allied Market Research
Discounted by 10% to 2024-11-15

The global corneal implant market was valued at $1,264.18 million in 2021, and is projected to reach $2,124.44 million by 2031, registering a CAGR of 5.3% from 2022 to 2031.
The outermost translucent portion of the eyeball's covering known as the cornea protects the iris and pupil while allowing light to enter the interior. It directs and concentrates light as it enters the eye. Between 65 and 75 percent of the eye's entire focusing power comes from the cornea.
A corneal transplant involves replacing a cloudy cornea with a clear donor cornea. Donor tissue comes from individuals who have donated their eyes for the benefit of others. The donor corneas used in transplants are kept freshly stored in eye banks. Furthermore, artificial cornea is an option for transplant patients who cannot tolerate a human donor cornea. In order to correct vision issues caused by various ocular disorders, corneal transplants are typically performed.
The global corneal implant market is expected to witness a substantial growth in the future, owing to surge in prevalence of eye diseases such as Fuchs' dystrophy, keratoconus keratitis, corneal scarring, corneal ulcers and corneal edema. People suffering from these ocular diseases need corneal transplantation on the basis of severity of diseases.
Furthermore, rise in incidences of corneal blindness is the primary factor that drives the growth of the cornea implant market. For instance, according to the SightLife organization more than 12.7 million people globally suffer from corneal blindness. Thus, rise in incidences of corneal blindness is the primary factor that drives the growth of the cornea implant market. In addition, increase in incidences of trauma cases lead to high chances of eye injury, which further propel the market growth.
Moreover, technological advancements in the development of the artificial cornea propel the market growth. Various key market players are involved in the development of the bioengineered artificial corneal implant which further drives the demand of the corneal implants subsequently flourish the market growth.
Furthermore, growth opportunities in emerging markets contribute towards the growth of the market. Availability of improved healthcare industry infrastructure, growth in number of pharmaceutical industries, and surge in incidence of the corneal disorders drives the growth of the market in emerging economies. However, low availability of human cornea donors and high risk in the grafting artificial cornea implant is expected to impede the market growth during the forecast period. Conversely, rise in geriatric population is a lucrative opportunity for the market growth. As the geriatric population is more susceptible to corneal diseases.
The global corneal implant market is segmented into type, disease type, transplant type, end user, and region. On the basis of disease type, the market is segregated into keratoconus, Fuchs' dystrophy, infectious keratitis and others. On the basis of transplant type, market is segmented into penetrating keratoplasty, anterior lamellar keratoplasty, endothelial keratoplasty and keratoprothesis. On the basis of end user, the market is categorized into hospitals, ambulatory surgical centers and ophthalmic centers. Region wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
Major Key players that operate in the global corneal implant market are Corneagen, Presbia Plc, Presbia Plc, mediphacos, Aurolab, AJL Opthalmic SA, LinkoCare Life Sciences AB, DIOPTEX, EyeYon Medical, and KeraMed, Inc.
Key Benefits For Stakeholders
-This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the corneal implants market analysis from 2021 to 2031 to identify the prevailing corneal implants market opportunities.
-The market research is offered along with information related to key drivers, restraints, and opportunities.
-Porter's five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
-In-depth analysis of the corneal implants market segmentation assists to determine the prevailing market opportunities.
-Major countries in each region are mapped according to their revenue contribution to the global market.
-Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
-The report includes the analysis of the regional as well as global corneal implants market trends, key players, market segments, application areas, and market growth strategies.
Key Market Segments
By Procedure Type
- Penetrating keratoplasty
- Endothelial keratoplasty
- Others
By Disease Type
- Keratoconus
- Fuchs' dystrophy
- Infectious keratitis
- Others
By End User
- Hospitals
- Ophthalmic centers
- Others
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Italy
- Spain
- Rest of Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- South Korea
- Rest of Asia-Pacific
- LAMEA
- Brazil
- Saudi Arabia
- South Africa
- Rest of LAMEA
- Key Market Players
- Presbia Plc
- CorNeat Vision
- Aurolab
- AJL Opthalmic SA
- LinkoCare Life Sciences AB
- CorneaGen
- DIOPTEX
- Mediphacos
- EyeYon Medical
- KeraMed, Inc

CHAPTER 1: INTRODUCTION
1.1. Report description
1.2. Key market segments
1.3. Key benefits to the stakeholders
1.4. Research Methodology
1.4.1. Primary research
1.4.2. Secondary research
1.4.3. Analyst tools and models
CHAPTER 2: EXECUTIVE SUMMARY
2.1. CXO Perspective
CHAPTER 3: MARKET OVERVIEW
3.1. Market definition and scope
3.2. Key findings
3.2.1. Top impacting factors
3.2.2. Top investment pockets
3.3. Porter's five forces analysis
3.3.1. Bargaining power of suppliers
3.3.2. Bargaining power of buyers
3.3.3. Threat of substitutes
3.3.4. Threat of new entrants
3.3.5. Intensity of rivalry
3.4. Market dynamics
3.4.1. Drivers
3.4.1.1. Rise in prevalence of corneal disorders
3.4.1.2. High growth potential in emerging markets
3.4.1.3. Technological advancements in the field of cornea

3.4.2. Restraints
3.4.2.1. Shortage of corneal donors

3.4.3. Opportunities
3.4.3.1. Increase in geriatric population

3.5. COVID-19 Impact Analysis on the market
CHAPTER 4: CORNEAL IMPLANTS MARKET, BY PROCEDURE TYPE
4.1. Overview
4.1.1. Market size and forecast
4.2. Penetrating keratoplasty
4.2.1. Key market trends, growth factors and opportunities
4.2.2. Market size and forecast, by region
4.2.3. Market share analysis by country
4.3. Endothelial keratoplasty
4.3.1. Key market trends, growth factors and opportunities
4.3.2. Market size and forecast, by region
4.3.3. Market share analysis by country
4.4. Others
4.4.1. Key market trends, growth factors and opportunities
4.4.2. Market size and forecast, by region
4.4.3. Market share analysis by country
CHAPTER 5: CORNEAL IMPLANTS MARKET, BY DISEASE TYPE
5.1. Overview
5.1.1. Market size and forecast
5.2. Keratoconus
5.2.1. Key market trends, growth factors and opportunities
5.2.2. Market size and forecast, by region
5.2.3. Market share analysis by country
5.3. Fuchs' dystrophy
5.3.1. Key market trends, growth factors and opportunities
5.3.2. Market size and forecast, by region
5.3.3. Market share analysis by country
5.4. Infectious keratitis
5.4.1. Key market trends, growth factors and opportunities
5.4.2. Market size and forecast, by region
5.4.3. Market share analysis by country
5.5. Others
5.5.1. Key market trends, growth factors and opportunities
5.5.2. Market size and forecast, by region
5.5.3. Market share analysis by country
CHAPTER 6: CORNEAL IMPLANTS MARKET, BY END USER
6.1. Overview
6.1.1. Market size and forecast
6.2. Hospitals
6.2.1. Key market trends, growth factors and opportunities
6.2.2. Market size and forecast, by region
6.2.3. Market share analysis by country
6.3. Ophthalmic centers
6.3.1. Key market trends, growth factors and opportunities
6.3.2. Market size and forecast, by region
6.3.3. Market share analysis by country
6.4. Others
6.4.1. Key market trends, growth factors and opportunities
6.4.2. Market size and forecast, by region
6.4.3. Market share analysis by country
CHAPTER 7: CORNEAL IMPLANTS MARKET, BY REGION
7.1. Overview
7.1.1. Market size and forecast By Region
7.2. North America
7.2.1. Key trends and opportunities
7.2.2. Market size and forecast, by Procedure Type
7.2.3. Market size and forecast, by Disease Type
7.2.4. Market size and forecast, by End User
7.2.5. Market size and forecast, by country
7.2.5.1. U.S.
7.2.5.1.1. Key market trends, growth factors and opportunities
7.2.5.1.2. Market size and forecast, by Procedure Type
7.2.5.1.3. Market size and forecast, by Disease Type
7.2.5.1.4. Market size and forecast, by End User
7.2.5.2. Canada
7.2.5.2.1. Key market trends, growth factors and opportunities
7.2.5.2.2. Market size and forecast, by Procedure Type
7.2.5.2.3. Market size and forecast, by Disease Type
7.2.5.2.4. Market size and forecast, by End User
7.2.5.3. Mexico
7.2.5.3.1. Key market trends, growth factors and opportunities
7.2.5.3.2. Market size and forecast, by Procedure Type
7.2.5.3.3. Market size and forecast, by Disease Type
7.2.5.3.4. Market size and forecast, by End User
7.3. Europe
7.3.1. Key trends and opportunities
7.3.2. Market size and forecast, by Procedure Type
7.3.3. Market size and forecast, by Disease Type
7.3.4. Market size and forecast, by End User
7.3.5. Market size and forecast, by country
7.3.5.1. Germany
7.3.5.1.1. Key market trends, growth factors and opportunities
7.3.5.1.2. Market size and forecast, by Procedure Type
7.3.5.1.3. Market size and forecast, by Disease Type
7.3.5.1.4. Market size and forecast, by End User
7.3.5.2. France
7.3.5.2.1. Key market trends, growth factors and opportunities
7.3.5.2.2. Market size and forecast, by Procedure Type
7.3.5.2.3. Market size and forecast, by Disease Type
7.3.5.2.4. Market size and forecast, by End User
7.3.5.3. UK
7.3.5.3.1. Key market trends, growth factors and opportunities
7.3.5.3.2. Market size and forecast, by Procedure Type
7.3.5.3.3. Market size and forecast, by Disease Type
7.3.5.3.4. Market size and forecast, by End User
7.3.5.4. Italy
7.3.5.4.1. Key market trends, growth factors and opportunities
7.3.5.4.2. Market size and forecast, by Procedure Type
7.3.5.4.3. Market size and forecast, by Disease Type
7.3.5.4.4. Market size and forecast, by End User
7.3.5.5. Spain
7.3.5.5.1. Key market trends, growth factors and opportunities
7.3.5.5.2. Market size and forecast, by Procedure Type
7.3.5.5.3. Market size and forecast, by Disease Type
7.3.5.5.4. Market size and forecast, by End User
7.3.5.6. Rest of Europe
7.3.5.6.1. Key market trends, growth factors and opportunities
7.3.5.6.2. Market size and forecast, by Procedure Type
7.3.5.6.3. Market size and forecast, by Disease Type
7.3.5.6.4. Market size and forecast, by End User
7.4. Asia-Pacific
7.4.1. Key trends and opportunities
7.4.2. Market size and forecast, by Procedure Type
7.4.3. Market size and forecast, by Disease Type
7.4.4. Market size and forecast, by End User
7.4.5. Market size and forecast, by country
7.4.5.1. Japan
7.4.5.1.1. Key market trends, growth factors and opportunities
7.4.5.1.2. Market size and forecast, by Procedure Type
7.4.5.1.3. Market size and forecast, by Disease Type
7.4.5.1.4. Market size and forecast, by End User
7.4.5.2. China
7.4.5.2.1. Key market trends, growth factors and opportunities
7.4.5.2.2. Market size and forecast, by Procedure Type
7.4.5.2.3. Market size and forecast, by Disease Type
7.4.5.2.4. Market size and forecast, by End User
7.4.5.3. India
7.4.5.3.1. Key market trends, growth factors and opportunities
7.4.5.3.2. Market size and forecast, by Procedure Type
7.4.5.3.3. Market size and forecast, by Disease Type
7.4.5.3.4. Market size and forecast, by End User
7.4.5.4. Australia
7.4.5.4.1. Key market trends, growth factors and opportunities
7.4.5.4.2. Market size and forecast, by Procedure Type
7.4.5.4.3. Market size and forecast, by Disease Type
7.4.5.4.4. Market size and forecast, by End User
7.4.5.5. South Korea
7.4.5.5.1. Key market trends, growth factors and opportunities
7.4.5.5.2. Market size and forecast, by Procedure Type
7.4.5.5.3. Market size and forecast, by Disease Type
7.4.5.5.4. Market size and forecast, by End User
7.4.5.6. Rest of Asia-Pacific
7.4.5.6.1. Key market trends, growth factors and opportunities
7.4.5.6.2. Market size and forecast, by Procedure Type
7.4.5.6.3. Market size and forecast, by Disease Type
7.4.5.6.4. Market size and forecast, by End User
7.5. LAMEA
7.5.1. Key trends and opportunities
7.5.2. Market size and forecast, by Procedure Type
7.5.3. Market size and forecast, by Disease Type
7.5.4. Market size and forecast, by End User
7.5.5. Market size and forecast, by country
7.5.5.1. Brazil
7.5.5.1.1. Key market trends, growth factors and opportunities
7.5.5.1.2. Market size and forecast, by Procedure Type
7.5.5.1.3. Market size and forecast, by Disease Type
7.5.5.1.4. Market size and forecast, by End User
7.5.5.2. Saudi Arabia
7.5.5.2.1. Key market trends, growth factors and opportunities
7.5.5.2.2. Market size and forecast, by Procedure Type
7.5.5.2.3. Market size and forecast, by Disease Type
7.5.5.2.4. Market size and forecast, by End User
7.5.5.3. South Africa
7.5.5.3.1. Key market trends, growth factors and opportunities
7.5.5.3.2. Market size and forecast, by Procedure Type
7.5.5.3.3. Market size and forecast, by Disease Type
7.5.5.3.4. Market size and forecast, by End User
7.5.5.4. Rest of LAMEA
7.5.5.4.1. Key market trends, growth factors and opportunities
7.5.5.4.2. Market size and forecast, by Procedure Type
7.5.5.4.3. Market size and forecast, by Disease Type
7.5.5.4.4. Market size and forecast, by End User
CHAPTER 8: COMPETITIVE LANDSCAPE
8.1. Introduction
8.2. Top winning strategies
8.3. Product Mapping of Top 10 Player
8.4. Competitive Dashboard
8.5. Competitive Heatmap
8.6. Top player positioning, 2021
CHAPTER 9: COMPANY PROFILES
9.1. Aurolab
9.1.1. Company overview
9.1.2. Key Executives
9.1.3. Company snapshot
9.1.4. Operating business segments
9.1.5. Product portfolio
9.2. AJL Opthalmic SA
9.2.1. Company overview
9.2.2. Key Executives
9.2.3. Company snapshot
9.2.4. Operating business segments
9.2.5. Product portfolio
9.3. CorneaGen
9.3.1. Company overview
9.3.2. Key Executives
9.3.3. Company snapshot
9.3.4. Operating business segments
9.3.5. Product portfolio
9.4. KeraMed, Inc
9.4.1. Company overview
9.4.2. Key Executives
9.4.3. Company snapshot
9.4.4. Operating business segments
9.4.5. Product portfolio
9.5. Presbia Plc
9.5.1. Company overview
9.5.2. Key Executives
9.5.3. Company snapshot
9.5.4. Operating business segments
9.5.5. Product portfolio
9.6. CorNeat Vision
9.6.1. Company overview
9.6.2. Key Executives
9.6.3. Company snapshot
9.6.4. Operating business segments
9.6.5. Product portfolio
9.7. Mediphacos
9.7.1. Company overview
9.7.2. Key Executives
9.7.3. Company snapshot
9.7.4. Operating business segments
9.7.5. Product portfolio
9.8. LinkoCare Life Sciences AB
9.8.1. Company overview
9.8.2. Key Executives
9.8.3. Company snapshot
9.8.4. Operating business segments
9.8.5. Product portfolio
9.9. EyeYon Medical
9.9.1. Company overview
9.9.2. Key Executives
9.9.3. Company snapshot
9.9.4. Operating business segments
9.9.5. Product portfolio
9.10. DIOPTEX
9.10.1. Company overview
9.10.2. Key Executives
9.10.3. Company snapshot
9.10.4. Operating business segments
9.10.5. Product portfolio

LIST OF TABLES
TABLE 01. GLOBAL CORNEAL IMPLANTS MARKET, BY PROCEDURE TYPE, 2021-2031 ($MILLION)
TABLE 02. CORNEAL IMPLANTS MARKET FOR PENETRATING KERATOPLASTY, BY REGION, 2021-2031 ($MILLION)
TABLE 03. CORNEAL IMPLANTS MARKET FOR ENDOTHELIAL KERATOPLASTY, BY REGION, 2021-2031 ($MILLION)
TABLE 04. CORNEAL IMPLANTS MARKET FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 05. GLOBAL CORNEAL IMPLANTS MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 06. CORNEAL IMPLANTS MARKET FOR KERATOCONUS, BY REGION, 2021-2031 ($MILLION)
TABLE 07. CORNEAL IMPLANTS MARKET FOR FUCHS' DYSTROPHY, BY REGION, 2021-2031 ($MILLION)
TABLE 08. CORNEAL IMPLANTS MARKET FOR INFECTIOUS KERATITIS, BY REGION, 2021-2031 ($MILLION)
TABLE 09. CORNEAL IMPLANTS MARKET FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 10. GLOBAL CORNEAL IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 11. CORNEAL IMPLANTS MARKET FOR HOSPITALS, BY REGION, 2021-2031 ($MILLION)
TABLE 12. CORNEAL IMPLANTS MARKET FOR OPHTHALMIC CENTERS, BY REGION, 2021-2031 ($MILLION)
TABLE 13. CORNEAL IMPLANTS MARKET FOR OTHERS, BY REGION, 2021-2031 ($MILLION)
TABLE 14. CORNEAL IMPLANTS MARKET, BY REGION, 2021-2031 ($MILLION)
TABLE 15. NORTH AMERICA CORNEAL IMPLANTS MARKET, BY PROCEDURE TYPE, 2021-2031 ($MILLION)
TABLE 16. NORTH AMERICA CORNEAL IMPLANTS MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 17. NORTH AMERICA CORNEAL IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 18. NORTH AMERICA CORNEAL IMPLANTS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 19. U.S. CORNEAL IMPLANTS MARKET, BY PROCEDURE TYPE, 2021-2031 ($MILLION)
TABLE 20. U.S. CORNEAL IMPLANTS MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 21. U.S. CORNEAL IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 22. CANADA CORNEAL IMPLANTS MARKET, BY PROCEDURE TYPE, 2021-2031 ($MILLION)
TABLE 23. CANADA CORNEAL IMPLANTS MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 24. CANADA CORNEAL IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 25. MEXICO CORNEAL IMPLANTS MARKET, BY PROCEDURE TYPE, 2021-2031 ($MILLION)
TABLE 26. MEXICO CORNEAL IMPLANTS MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 27. MEXICO CORNEAL IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 28. EUROPE CORNEAL IMPLANTS MARKET, BY PROCEDURE TYPE, 2021-2031 ($MILLION)
TABLE 29. EUROPE CORNEAL IMPLANTS MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 30. EUROPE CORNEAL IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 31. EUROPE CORNEAL IMPLANTS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 32. GERMANY CORNEAL IMPLANTS MARKET, BY PROCEDURE TYPE, 2021-2031 ($MILLION)
TABLE 33. GERMANY CORNEAL IMPLANTS MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 34. GERMANY CORNEAL IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 35. FRANCE CORNEAL IMPLANTS MARKET, BY PROCEDURE TYPE, 2021-2031 ($MILLION)
TABLE 36. FRANCE CORNEAL IMPLANTS MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 37. FRANCE CORNEAL IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 38. UK CORNEAL IMPLANTS MARKET, BY PROCEDURE TYPE, 2021-2031 ($MILLION)
TABLE 39. UK CORNEAL IMPLANTS MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 40. UK CORNEAL IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 41. ITALY CORNEAL IMPLANTS MARKET, BY PROCEDURE TYPE, 2021-2031 ($MILLION)
TABLE 42. ITALY CORNEAL IMPLANTS MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 43. ITALY CORNEAL IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 44. SPAIN CORNEAL IMPLANTS MARKET, BY PROCEDURE TYPE, 2021-2031 ($MILLION)
TABLE 45. SPAIN CORNEAL IMPLANTS MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 46. SPAIN CORNEAL IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 47. REST OF EUROPE CORNEAL IMPLANTS MARKET, BY PROCEDURE TYPE, 2021-2031 ($MILLION)
TABLE 48. REST OF EUROPE CORNEAL IMPLANTS MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 49. REST OF EUROPE CORNEAL IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 50. ASIA-PACIFIC CORNEAL IMPLANTS MARKET, BY PROCEDURE TYPE, 2021-2031 ($MILLION)
TABLE 51. ASIA-PACIFIC CORNEAL IMPLANTS MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 52. ASIA-PACIFIC CORNEAL IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 53. ASIA-PACIFIC CORNEAL IMPLANTS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 54. JAPAN CORNEAL IMPLANTS MARKET, BY PROCEDURE TYPE, 2021-2031 ($MILLION)
TABLE 55. JAPAN CORNEAL IMPLANTS MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 56. JAPAN CORNEAL IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 57. CHINA CORNEAL IMPLANTS MARKET, BY PROCEDURE TYPE, 2021-2031 ($MILLION)
TABLE 58. CHINA CORNEAL IMPLANTS MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 59. CHINA CORNEAL IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 60. INDIA CORNEAL IMPLANTS MARKET, BY PROCEDURE TYPE, 2021-2031 ($MILLION)
TABLE 61. INDIA CORNEAL IMPLANTS MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 62. INDIA CORNEAL IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 63. AUSTRALIA CORNEAL IMPLANTS MARKET, BY PROCEDURE TYPE, 2021-2031 ($MILLION)
TABLE 64. AUSTRALIA CORNEAL IMPLANTS MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 65. AUSTRALIA CORNEAL IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 66. SOUTH KOREA CORNEAL IMPLANTS MARKET, BY PROCEDURE TYPE, 2021-2031 ($MILLION)
TABLE 67. SOUTH KOREA CORNEAL IMPLANTS MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 68. SOUTH KOREA CORNEAL IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 69. REST OF ASIA-PACIFIC CORNEAL IMPLANTS MARKET, BY PROCEDURE TYPE, 2021-2031 ($MILLION)
TABLE 70. REST OF ASIA-PACIFIC CORNEAL IMPLANTS MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 71. REST OF ASIA-PACIFIC CORNEAL IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 72. LAMEA CORNEAL IMPLANTS MARKET, BY PROCEDURE TYPE, 2021-2031 ($MILLION)
TABLE 73. LAMEA CORNEAL IMPLANTS MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 74. LAMEA CORNEAL IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 75. LAMEA CORNEAL IMPLANTS MARKET, BY COUNTRY, 2021-2031 ($MILLION)
TABLE 76. BRAZIL CORNEAL IMPLANTS MARKET, BY PROCEDURE TYPE, 2021-2031 ($MILLION)
TABLE 77. BRAZIL CORNEAL IMPLANTS MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 78. BRAZIL CORNEAL IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 79. SAUDI ARABIA CORNEAL IMPLANTS MARKET, BY PROCEDURE TYPE, 2021-2031 ($MILLION)
TABLE 80. SAUDI ARABIA CORNEAL IMPLANTS MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 81. SAUDI ARABIA CORNEAL IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 82. SOUTH AFRICA CORNEAL IMPLANTS MARKET, BY PROCEDURE TYPE, 2021-2031 ($MILLION)
TABLE 83. SOUTH AFRICA CORNEAL IMPLANTS MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 84. SOUTH AFRICA CORNEAL IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 85. REST OF LAMEA CORNEAL IMPLANTS MARKET, BY PROCEDURE TYPE, 2021-2031 ($MILLION)
TABLE 86. REST OF LAMEA CORNEAL IMPLANTS MARKET, BY DISEASE TYPE, 2021-2031 ($MILLION)
TABLE 87. REST OF LAMEA CORNEAL IMPLANTS MARKET, BY END USER, 2021-2031 ($MILLION)
TABLE 88. AUROLAB: KEY EXECUTIVES
TABLE 89. AUROLAB: COMPANY SNAPSHOT
TABLE 90. AUROLAB: PRODUCT SEGMENTS
TABLE 91. AUROLAB: PRODUCT PORTFOLIO
TABLE 92. AJL OPTHALMIC SA: KEY EXECUTIVES
TABLE 93. AJL OPTHALMIC SA: COMPANY SNAPSHOT
TABLE 94. AJL OPTHALMIC SA: PRODUCT SEGMENTS
TABLE 95. AJL OPTHALMIC SA: PRODUCT PORTFOLIO
TABLE 96. CORNEAGEN: KEY EXECUTIVES
TABLE 97. CORNEAGEN: COMPANY SNAPSHOT
TABLE 98. CORNEAGEN: PRODUCT SEGMENTS
TABLE 99. CORNEAGEN: PRODUCT PORTFOLIO
TABLE 100. KERAMED, INC: KEY EXECUTIVES
TABLE 101. KERAMED, INC: COMPANY SNAPSHOT
TABLE 102. KERAMED, INC: PRODUCT SEGMENTS
TABLE 103. KERAMED, INC: PRODUCT PORTFOLIO
TABLE 104. PRESBIA PLC: KEY EXECUTIVES
TABLE 105. PRESBIA PLC: COMPANY SNAPSHOT
TABLE 106. PRESBIA PLC: PRODUCT SEGMENTS
TABLE 107. PRESBIA PLC: PRODUCT PORTFOLIO
TABLE 108. CORNEAT VISION: KEY EXECUTIVES
TABLE 109. CORNEAT VISION: COMPANY SNAPSHOT
TABLE 110. CORNEAT VISION: PRODUCT SEGMENTS
TABLE 111. CORNEAT VISION: PRODUCT PORTFOLIO
TABLE 112. MEDIPHACOS: KEY EXECUTIVES
TABLE 113. MEDIPHACOS: COMPANY SNAPSHOT
TABLE 114. MEDIPHACOS: PRODUCT SEGMENTS
TABLE 115. MEDIPHACOS: PRODUCT PORTFOLIO
TABLE 116. LINKOCARE LIFE SCIENCES AB: KEY EXECUTIVES
TABLE 117. LINKOCARE LIFE SCIENCES AB: COMPANY SNAPSHOT
TABLE 118. LINKOCARE LIFE SCIENCES AB: PRODUCT SEGMENTS
TABLE 119. LINKOCARE LIFE SCIENCES AB: PRODUCT PORTFOLIO
TABLE 120. EYEYON MEDICAL: KEY EXECUTIVES
TABLE 121. EYEYON MEDICAL: COMPANY SNAPSHOT
TABLE 122. EYEYON MEDICAL: PRODUCT SEGMENTS
TABLE 123. EYEYON MEDICAL: PRODUCT PORTFOLIO
TABLE 124. DIOPTEX: KEY EXECUTIVES
TABLE 125. DIOPTEX: COMPANY SNAPSHOT
TABLE 126. DIOPTEX: PRODUCT SEGMENTS
TABLE 127. DIOPTEX: PRODUCT PORTFOLIO

LIST OF FIGURES
FIGURE 01. CORNEAL IMPLANTS MARKET, 2021-2031
FIGURE 02. SEGMENTATION OF CORNEAL IMPLANTS MARKET, 2021-2031
FIGURE 03. TOP INVESTMENT POCKETS IN CORNEAL IMPLANTS MARKET (2022-2031)
FIGURE 04. MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 05. MODERATE BARGAINING POWER OF BUYERS
FIGURE 06. MODERATE THREAT OF SUBSTITUTES
FIGURE 07. HIGH THREAT OF NEW ENTRANTS
FIGURE 08. MODERATE INTENSITY OF RIVALRY
FIGURE 09. DRIVERS, RESTRAINTS AND OPPORTUNITIES: GLOBALCORNEAL IMPLANTS MARKET
FIGURE 10. CORNEAL IMPLANTS MARKET, BY PROCEDURE TYPE, 2021(%)
FIGURE 11. COMPARATIVE SHARE ANALYSIS OF CORNEAL IMPLANTS MARKET FOR PENETRATING KERATOPLASTY, BY COUNTRY 2021 AND 2031(%)
FIGURE 12. COMPARATIVE SHARE ANALYSIS OF CORNEAL IMPLANTS MARKET FOR ENDOTHELIAL KERATOPLASTY, BY COUNTRY 2021 AND 2031(%)
FIGURE 13. COMPARATIVE SHARE ANALYSIS OF CORNEAL IMPLANTS MARKET FOR OTHERS, BY COUNTRY 2021 AND 2031(%)
FIGURE 14. CORNEAL IMPLANTS MARKET, BY DISEASE TYPE, 2021(%)
FIGURE 15. COMPARATIVE SHARE ANALYSIS OF CORNEAL IMPLANTS MARKET FOR KERATOCONUS, BY COUNTRY 2021 AND 2031(%)
FIGURE 16. COMPARATIVE SHARE ANALYSIS OF CORNEAL IMPLANTS MARKET FOR FUCHS' DYSTROPHY, BY COUNTRY 2021 AND 2031(%)
FIGURE 17. COMPARATIVE SHARE ANALYSIS OF CORNEAL IMPLANTS MARKET FOR INFECTIOUS KERATITIS, BY COUNTRY 2021 AND 2031(%)
FIGURE 18. COMPARATIVE SHARE ANALYSIS OF CORNEAL IMPLANTS MARKET FOR OTHERS, BY COUNTRY 2021 AND 2031(%)
FIGURE 19. CORNEAL IMPLANTS MARKET, BY END USER, 2021(%)
FIGURE 20. COMPARATIVE SHARE ANALYSIS OF CORNEAL IMPLANTS MARKET FOR HOSPITALS, BY COUNTRY 2021 AND 2031(%)
FIGURE 21. COMPARATIVE SHARE ANALYSIS OF CORNEAL IMPLANTS MARKET FOR OPHTHALMIC CENTERS, BY COUNTRY 2021 AND 2031(%)
FIGURE 22. COMPARATIVE SHARE ANALYSIS OF CORNEAL IMPLANTS MARKET FOR OTHERS, BY COUNTRY 2021 AND 2031(%)
FIGURE 23. CORNEAL IMPLANTS MARKET BY REGION, 2021
FIGURE 24. U.S. CORNEAL IMPLANTS MARKET, 2021-2031 ($MILLION)
FIGURE 25. CANADA CORNEAL IMPLANTS MARKET, 2021-2031 ($MILLION)
FIGURE 26. MEXICO CORNEAL IMPLANTS MARKET, 2021-2031 ($MILLION)
FIGURE 27. GERMANY CORNEAL IMPLANTS MARKET, 2021-2031 ($MILLION)
FIGURE 28. FRANCE CORNEAL IMPLANTS MARKET, 2021-2031 ($MILLION)
FIGURE 29. UK CORNEAL IMPLANTS MARKET, 2021-2031 ($MILLION)
FIGURE 30. ITALY CORNEAL IMPLANTS MARKET, 2021-2031 ($MILLION)
FIGURE 31. SPAIN CORNEAL IMPLANTS MARKET, 2021-2031 ($MILLION)
FIGURE 32. REST OF EUROPE CORNEAL IMPLANTS MARKET, 2021-2031 ($MILLION)
FIGURE 33. JAPAN CORNEAL IMPLANTS MARKET, 2021-2031 ($MILLION)
FIGURE 34. CHINA CORNEAL IMPLANTS MARKET, 2021-2031 ($MILLION)
FIGURE 35. INDIA CORNEAL IMPLANTS MARKET, 2021-2031 ($MILLION)
FIGURE 36. AUSTRALIA CORNEAL IMPLANTS MARKET, 2021-2031 ($MILLION)
FIGURE 37. SOUTH KOREA CORNEAL IMPLANTS MARKET, 2021-2031 ($MILLION)
FIGURE 38. REST OF ASIA-PACIFIC CORNEAL IMPLANTS MARKET, 2021-2031 ($MILLION)
FIGURE 39. BRAZIL CORNEAL IMPLANTS MARKET, 2021-2031 ($MILLION)
FIGURE 40. SAUDI ARABIA CORNEAL IMPLANTS MARKET, 2021-2031 ($MILLION)
FIGURE 41. SOUTH AFRICA CORNEAL IMPLANTS MARKET, 2021-2031 ($MILLION)
FIGURE 42. REST OF LAMEA CORNEAL IMPLANTS MARKET, 2021-2031 ($MILLION)
FIGURE 43. TOP WINNING STRATEGIES, BY YEAR
FIGURE 44. TOP WINNING STRATEGIES, BY DEVELOPMENT
FIGURE 45. TOP WINNING STRATEGIES, BY COMPANY
FIGURE 46. PRODUCT MAPPING OF TOP 10 PLAYERS
FIGURE 47. COMPETITIVE DASHBOARD
FIGURE 48. COMPETITIVE HEATMAP: CORNEAL IMPLANTS MARKET
FIGURE 49. TOP PLAYER POSITIONING, 2021

  • Not Sure / Need Reassuring
    • Confirm Content

      • Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:

        Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.

        Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.

        Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.

    • Sample Pages

      • With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.

        It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.

        To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Check for Alternatives

      • Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.

        To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.

  • Prices / Formats / Delivery
    • Prices

      • All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.

        Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Discounts

      • As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.

        Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.

        To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.

    • Available Currencies

      • Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.

        Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.

        To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.

    • Licenses

      • License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Global Site License

      • The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.

        It is important to note that this may exclude Parent Companies or Subsidiaries.

        If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.

    • Formats

      • The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.

        If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.

    • Delivery

      • Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.

        Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.

        If a delay in delivery is expected you will be informed about it immediately.

    • Shipping Charges

      • As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.

        If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.

  • Ordering
    • By Credit Card

      • We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.

        Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.

        For more information on PayU please visit: https://www.payu.pl/en/about-us

    • By Money Transfer

      • If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.

        With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.

  • Security
    • Website security

      • We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.

        Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.

    • Credit Card Security

      • We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.

        PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.

PLEASE SELECT LICENSE
  • $3456.00 $3110.40
  • $5730.00 $5157.00
  • $9600.00 $8640.00
  • ADD TO BASKET
  • BUY NOW